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Summary: Two commercially available test kits for the determination of carcinoembryonic antigen (CEA) in human
plasma were compared with each other under various experimental conditions.
These studies were carried out
(a) with an indirect method (Hoffmann-La Roche), in which the plasma sample is extracted by perchloric acid, and .
(b) with a direct method (CEA-IRE-SORIN) without prior treatment of the plasma.
Using plasma from patients with cancer, the CEA values, obtained by the direct method, were about 5 times higher
on the average than those determined by the indirect procedure. This result is primarily due to the quantitative diffe-
rences between the different standard preparations. Perchloric acid which served to extract CEA from the plasma had
significantly less influence. The standard buffer of the CEA-IRE-SORIN-assay did not affect the level of plasma CEA;
in contrast, when the standard buffer of the Hoffmann-La Roche assay was used, the CEA values were lower when
compared with a buffer with a protein composition similar to that of the sample to be investigated. These results
strongly indicate that a standardised method with an internationally accepted CEA standard is required for the quan-
titative determination of CEA.
Einflußgrößen bei der radioimmunologischen Bestimmung des carcinoembryonalen Antigens im Plasma des Menschen
Zusammenfassung: Zwei kommerzielle Testkits zur Bestimmung des carcinoembryonalen Antigens (CEA) im Plasma
des Menschen wurden unter verschiedenen Gesichtspunkten miteinander verglichen. Dabei handelte es sich einmal
um eine indirekte Bestimmungsmethode (Hoffmann-La Roche), bei der die zu untersuchende Plasmprobe mit Per-
chlorsäure extrahiert wurde, zum anderen um ein direktes Verfahren (CEA-IRE-SORIN) ohne Vorbehandlung des
Plasmas.
Die mit der direkten Methode ermittelten CEA-Werte bei Carcinompatienten lagen im Durchschnitt etwa fünfmal
höher als bei Verwendung des indirekten Verfahrens. Dieser Befund ist hauptsächlich auf die quantitativen Unter-
schiede zwischen den verschiedenen Standardpräparationen zurückzuführen. Einen deutlich geringeren Einfluß hatte
die Verwendung von Perchlorsäure, die zur Extraktion von CEA diente. Während der Standardpuffer im CEA-IRE-
SORIN-Assay ohne Wirkung auf die Höhe der gemessenen CEA-Konzentrationen war, lagen die CEA-Werte bei Ver-
wendung des Standardpuffers des Hoffmann-La Roche:Assay niedriger im Vergleich mit einem Puffer, dessen Pro-
teinzusammensetzung mit derjenigen der zu untersuchenden Probe identisch war.
Diese Ergebnisse unterstützen die Forderung nach standardisierten Methoden zur Bestimmung von CEA unter Ver-
wendung eines international akzeptierten CEA-Standards.
Introduction Furthermore, the absorption of the antisera seems to
have an influence on the radioimmunological CEA de-
It has been reported that CEA plasma levels and the upper termination (3). Moreover, several authors reported higher
limit of the normal range as measured by radioimmuno- CEA concentrations when the extraction of plasma or
assay depend on several factors. Thus, different stand- serum with perchloric acid was omitted (4, 5, 6). Fir.
ard preparations may lead to different results (1, 2). nally, the choice of the standard buffer and its protein
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content play an important role in the CEA radioimmuno-
assays(3,4,7).
In the present study, two commercially available radio-
immunoassays for the determination of CEA were conl··
pared; the two assays differ with respect to
(a) the standard preparation,
(b) absorption of antisera,
(c) extraction of the plasma with perchloric acid arid
(d) the buffer used for the standard determination.
Each of these factors may affect the radioimmunologi-
cal determination of CEA. Accordingly, the influence of
various standard preparations and buffers as well as of
the extraction with perchloric acid were studied in de-
tail.
Materials and Methods
The reagents for the radioimmunoassay of CEA in plasma were
obtained from Hoffmann-La Roche, Basel, Switzerland, and
from CEA-IRE-SORIN (CIS), distributed by Isotopendienst West,
F. R. Germany. Blood was collected in EDTA vacutainers
(Becton & Dickinson, Heidelberg, F. R. Germany). If not stated
otherwise, the assays were performed according to the instruc-
tions of the manufacturers. In the indirect Hoffmann-La Roche
assay, the plasma sample is extracted with 0.6 mol/1 perchloric
acid before CEA is assayed. In the direct CIS assay the plasma
sample is analysed-without prior extraction.
The CIS assay was also performed with perchloric acid-extracted
plasma samples (indkect determination). For this purpose plasma
was extracted in 0.6 mol/1 perchloric acid, dialysed four times
against deionised water and finally against 0.02 mol/1 barbital
buffer, pH 8.3. 0.1 ml of the nondialysable residue was used for
the assay. For the standard curve, normal plasma, supplied by
the manufacturer, was extracted in 0.6 mol/1 perchloric acid and
dialysed as described; 0.1 ml was used. In order to obtain con-
ditions which were comparable to those of the original direct
assay, 50 μΐ of non-extracted plasma with no detectable CEA
was taken from a pool of normal non-smokers, and was pipetted
into all tubes.
Binding of proteins to CEA was investigated by stirring the
plasma in 3 mol/1 NaCl solution for 2 h at room temperature
before extraction with perchloric acid (8,9). The perchloric acid
extract was processed as mentioned above. In a patient with very
high CEA concentrations in plasma, the binding curve was com-
pared with the binding of the standards pf both the CIS and the
Hoffmann-La Roche assay, using the Hoffmann-La Roche anti-
serum (for details, see 1. c. (10)).
t-test and regression analysis were performed as usual. As non-
parametrical test, the Wilcoxon matched pairs signed rank test
was applied. Standards were measured in triplicate and samples
in duplicate.
Results
The fraction of false positive results was determined in a
plasma panel, containing 55 plasma samples from 37 pa-
tients with various nonmalignant diseases (liver cirrhosis,
hepatitis, ulcerative colitis, Crohn's disease, gastric and
duodenal ulcer, emphysema, bronchitis, pneumonia, tuber-
culosis) and from 18 heavy smokers.
In 46 of the 55 subjects, CEA concentrations were nor-
mal in both the Hoffmann-La Roche assay and the CIS
assay; in two subjects, CEA was elevated in both assays.
Three subjects had normal GEA values in the CIS assay,
but exhibited elevated concentrations in the Hoffmann-
La Roche assay. On the other hand, four subjects showed
elevated values in the CIS assay, but normal values in
the Hoffmann-La Roche assay.
In 42 patients with gastrointestinal malignancies and
eight patients with bronchial carcinomas, preoperative
plasma concentrations were determined by both me-
thods (fig. 1). The fraction of false negative results was
lower in the direct CIS assay (0.42) than in the indirect
Hoffmann-La Roche assay (0.52). The median of the
50 patients in the direct method was 13.6 μ§/1 and in
the in direct method 2.4 |ug/l. Calculation of the re-
gression of the values within the limits of detection
(y = 9.1 X - 10.8) yielded a coefficient of correlation of
r = 0.91 (excluding one outlier).
In 26 patients, the CIS assay was performed by its origi-
nal (direct) and by a modified (indirect) procedure
(fig. 2). The values, obtained by the direct procedure
were significantly higher than those detected by the in-
direct method (p < 0.01). The median for the direct CIS
assay was 16.7 μg/l and that for the indirect assay
12.7 /zg/1. The values within the limits of detection gave
a regression of y - 0.86 χ + 12.44, r = 0.83.
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Fig. L Preoperative plasma concentrations of CEA in patients
with gastrointestinal and bronchial carcinomas, measured
with the direct CEA-IRE-SORIN and the indirect Hoff-
mann-La Roche assay.
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Fig. 2. Direct and indirect determination of plasma-CEA by the
CIS assay in patients with malignant and nonmalignant
diseases.
In figure 3, the concentrations of CEA as measured by
the original (indirect) Hoffmann-La Roche assay and by
the modified (indirect) CIS assay were compared. In the
indirect CIS assay, the CEA values were clearly higher
(median 11.6 Mg/1) than in the indirect Hoffmann- La
Roche assay (2.3 μg/l). The concentrations gave a re-
gression of y = 4.4 χ - 0.06, r = 0.86.
In one patient, CEA concentrations, as measured by the
direct CIS assay and the indirect Hoffmann-La Roche
assay, were highly discordant. One preoperative and
three postoperative determinations yielded values of
less than 2.5 μg/l in the Hoffmann-La Roche assay,
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Fig. 3. Indirect determination of plasma CEA by the Hoffmann-
La Roche and the CIS assays in patients with malignant
and nonmalignant diese ases.
whereas in the CIS assay the CEA concentrations varied
between 62 and 304 μ§/1. Treatment of the plasma with
3 mol/1 NaCl prior to extraction with perchloric acid did
not result in higher values. In the CIS assay, a significant
decrease in the concentration from 103 to less than
5 Mg/1 was observed, when the plasma sample was treated
with perchloric acid prior to the determination.
Double dilutions of a plasma sample with a high CEA
content were analysed by the Hoffmann-La Roche
assay; in addition, the same samples were measured
using the CIS standard instead of the Roche standard.
The results are summarised in table 1. As can be seen,
higher plasma values are estimated with the CIS standard.
Furthermore, with increasing dilution of the plasma
sample, the CEA values show a tendency to rise, when
the CIS standard is used for calculation.
According to the instructions of the manufacturer, the
standard in the CIS assay system is analysed in the same
buffer as the plasma samples. To obtain a comparable
protein content, normal plasma from a plasma pool is
added instead of the sample to be investigated. The CEA
content of the normal plasma which is supplied by the
manufacturer (CEA-IRE-SORIN) was found to be less
than 0.8 Mg/1 in the Hoffmann-La Roche assay.
In the Hoffmann-La Roche assay, the standard is measured
in a buffer that is different from the buffer against which
the perchloric acid-extracted plasma samples are dialysed.
The influence of different buffers and their protein con-
tent on the standard curve is shown in figure 4. The use
of a protein-free 0.01 mol/1 ammonium acetate buffer,
pH 6.8, leads to an over-estimation of CEA; in contrast,
the use of EDTA buffer, as supplied by Hoffmann-La
Roche for the standard curve, leads to an under-estima-
tion of CEA in the higher concentration range, when
compared with a standard curve performed in the dia-
lysed perchloric acid extracts from a normal human
plasma pool.
Using the same plasma pool, the interassay variance was
lower in the direct CIS assay; the coefficient of variation
of the same plasma sample was 5.7% in the direct CIS
assay (x = 40.4 μg/l), which yields higher results, and
11.1 % in the indirect Hoffmann-La Roche (x = 8.1 jug/1)
which yields lower results.
Table 1. Determination of CEA in different dilutions of the same
plasma using the Hoffmann-La Roche and the CIS stan-
dards.
Antiserum: Hoffmann-La Roche.
Dilution
of plasma sample
1: 8
1:16
1:32
1:64
CEA-Roche
942
1,084
969
1,017
CEA-CIS
2,014
2,541
2,794
2,800
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Fig. 4. CEA standard curves using different buffers in the Hoff-
mann-La Roche assay,
ο—ο 0.01 mol/1 ammonium acetate buffer
•—· 0.01 mol/1 ammonium acetate buffer containing
perchloric acid-extracted normal plasma
> Buffer received from Hoffmann-La Roche
Discussion
In the present paper, it has been demonstrated that the
results of CEA determinations in human plasma are
strongly influenced by a number of factors, including
the standard preparations, the perchloric acid extraction
and the different buffers, which were studied in more
detail.
Influence of standard preparations
In has been previously described that more CEA-CIS than
CEA-Roche is needed to reach a comparable inhibition
in the radioimmunoassay of CEA (10). As shown in the
table and in figure 3, this leads to higher value for plasma
CEA, when the CIS standard is used. These findings are
in agreement with the results reported by Ashman et al.
(1) and Vrba et al. (11). In contrast, Persijn &Korsten
(12) found that the standard curves obtained with Hoff-
mann-La Roche standard and antiserum on the one
hand and Hoffmann-La Roche antiserum and standard
according toKrupey et al. (13) on the other hand, were
completely superimposable. If one accepts that different
standard preparations result in different CEA serum
concentrations, then one would expect that the upper
limit of the normal range of CEA depends on the stand-
ard preparation used. Surprisingly, this seems not to be
the case, since in many investigations the upper limit
was between 2.5 and 3 Mg/1 irrespective of the standard
preparation used. This finding applies to the direct assay
(12, 14,15) as well as to the indirect assay (14, 16,17).
The contradictory results mentioned above may be ex-
plained by the varying water content (18), the salt
concentration (12) or different isolation procedures
(18,19) of the standard preparations. There were also
qualitative differences demonstrable between the CIS
standard on the one hand and plasma CEA on the other
hand (table 1). This finding is in agreement with the
results reported previously (10), where heterogenous
behaviour of tumour CEA was demonstrable in the
CIS assay.
It follows that a standardised procedure for the isolation
of CEA appears to be a prerequisite for a reliable deter-
mination of CEA in plasma.
Influence of extraction with perchloric acid
The influence of extraction with perchloric acid on the
CEA concentrations was observed after perchloric acid
strated in figure 2. After extraction of plasma with per-
chloric acid, the levels of CEA were significantly lower,
compared with the results obtained using the direct
assay. In some patients, a highly significant decrease in
CEA concentrations was observed after perchloric acid
extraction. In one patient, pre- and postoperative CEA
concentrations lay between 100 and 300 μg/l in the
direct assay, but were undetectable in the indirect Hoff-
mann-La Roche and CIS assays. Perchloric acid insolubility
in this case could not be traced to the binding of CEA by
perchloric acid4nsoluble proteins, since treatment with
high molar sodium chloride solution prior to extraction
with perchloric acid did not result in higher CEA values.
Though perchloric acid-insoluble species of CEA were
found in a certain percentage of patients, the quantita-
tive differences between the indirect Hoffmann-La Roche
and the direct CIS assay are primarily due to quantita-
tive differences between the standard preparations
(fig. 3).
The results in the literature concerning the effect of per-
chloric acid extraction on the CEA plasma concentra-
tions are also contradictory. Some authors reported
higher values for CEA in the direct assay (4, 5, 6) and a
higher percentage of false positive results (20). Others
found no significant differences with respect to the
upper limits of the normal range when extraction with
perchloric acid was omitted (12,14, 15,21). Comparing
the direct arid the indirect methods, factors such as the
source and the absorption of antisera as well as the
standard isolation procedures may play an important
role. .
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Influence of buffers
To attain similar protein concentrations in the sample
and standard tubes, plasma from normal subjects is
added to the standards in the CIS assay. As has been
pointed out by Kupchik et al. (7) and Sorokin et al.
(17), CEA-containing plasma from normal subjects which
is added to the standard tubes can cause an under-estima-
tion of CEA in the samples. In fact, when normal plasma
used in the CIS assay was measured for CEA content by
the indirect Hoffmann-La Roche assay, no detectable
CEA was found. Thus, it can be concluded that the use
of normal plasma has no significant influence on the CEA
levels in the CIS assay.
In the Hoffmann-La Roche assay, the standard buffer is
different from the buffer in which the samples are ana-
lysed. This causes an under-estimation of CEA in the con-
centration range above 2 μ§/1 (fig. 4). The differences
between the CEA values, as measured by the two assays
may in part be due to this effect. As was pointed out by
various authors, the protein content of the standard
buffer significantly influences the result of CEA deter-
mination (3,4, 7, 12).
Antisera
The influence of the source and of the absorption of the
antisera on the results of the radioimmunoassay of CEA
is not yet clear. It was not further investigated, because
commercial kits were used.
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